全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Metastatic Secondary Anaplastic Meningioma

DOI: 10.4236/oalib.1103170, PP. 1-6

Subject Areas: Oncology, Neurology

Keywords: Anaplastic Meningioma, Chemotherapy, Target Therapy, Stereotactic Radiosurgery

Full-Text   Cite this paper   Add to My Lib

Abstract

Usually, meningiomas are benign neoplasms and their malignant behavior is limited to local recurrence and brain invasion. The rate of local recurrence increases according to histological grade as reported by WHO criteria while extracranial metastases are rare. Anaplastic meningiomas (AM) represent the most rare and aggressive subtype of all meningiomas. This tumor may progress from lower grade I or II meningiomas (secondary AM) or develops as de novo disease (primary AM). We report a case of extracranial metastatic progression of a heavily treated intracranial secondary anaplastic meningioma. The metastatic progression was detected as unexpected and unsuspected diagnosis because it occurred in absence of local intracranial recurrence. There are no criteria to evaluate the risk for the metastatic spread. In hindsight, a malignant progression in tumor histological grade and a significant increase of ki-67 index represent useful predictors of the aggressive behavior.

Cite this paper

Santorsa, L. , Lorusso, F. , Divella, R. , Gentile, A. , Mazzocca, A. , Fazio, P. D. , Troiani, L. , Lotesoriere, C. , Campanella, G. , Bagnoli, J. and Lolli, I. (2016). Metastatic Secondary Anaplastic Meningioma. Open Access Library Journal, 3, e3170. doi: http://dx.doi.org/10.4236/oalib.1103170.

References

[1]  Claus, E.B., Bondy, M.L., Schildkraut, J.M., Wiemels, J.L., Wrensch, M. and Black, P.M. (2005) Epidemiology of Intracranial Meningioma. Neurosurgery, 57, 1088-1095.
https:/doi.org/10.1227/01.NEU.0000188281.91351.B9
[2]  Juratli, T. Geiger, K. and Lautenschlaeger, T. (2014) Primary and Secondary Malignant Meningiomas: A Clinical and Histological Comparison. Journal of Clinical Oncology, 32, 5s.
[3]  Sumrall, A.L. and Turner, S. (2012) Bevacizumab Therapy for Adults with Recurrent/Pro- gressive Meningioma: A Retrospective Series. Journal of Neuro-Oncology, 109, 63-70.
https:/doi.org/10.1007/s11060-012-0861-0
[4]  Fabi, A., Nuzzo, C., Vidiri, A., Ciccarese, M., Felici, A., Cattani, F. and Cognetti, F. (2006) Bone and Lung Metastases from Intracranial Meningioma. Anticancer Research, 26, 3835- 3837.
[5]  Chamberlain, M.C., Glantz, M.J. and Fadul, C.E. (2007) Recurrent Meningioma: Salvage Therapy with Long-Acting Somatostatin Analogue. Neurology, 69, 969-973.
https:/doi.org/10.1212/01.wnl.0000271382.62776.b7
[6]  Kanthan, R. and Senger. J.L. (2013) Distant Metastases from Meningiomas: A Myth or Reality? Annals of Clinical Pathology, 1, 1001.
[7]  Estanislau, E.S., Carvalho, G.T., Reis, B.L., et al. (2009) Malignant Meningioma with Extracranial Metastases. Arquivos de Neuro-Psiquiatria, 67, 730-732.
https:/doi.org/10.1590/S0004-282X2009000400036
[8]  Cachia, D., Alderson, L., Smith, T. and Yunus, S. (2012) Widely Metastatic Meningioma. Archives of Neurology, 69, 1372-1373.
https:/doi.org/10.1001/archneurol.2012.1
[9]  Bollag, R.J., Vender, J.R. and Sharma, S. (2010) Anaplastic Meningioma: Progression from Atypical and Chordoid Morphotype with Morphological Spectral Variation at Recurrence. Neuropathology, 30, 279-287.
https:/doi.org/10.1111/j.1440-1789.2009.01060.x
[10]  Torp, S.H., Lindboe, C.F., Gronberg, B.H., Lydersen, S. and Sundstrom, S. (2005) Prognostic Significance of ki-67/mib-1 Proliferation Index in Meningiomas. Clinical Neuropathology, 24, 170-174.
[11]  Wen, P.Y., Quant, E., Drappats, J., Beroukhim, R. and Norden, A.D. (2010) Medical Therapies for Meningiomas. Journal of Neuro-Oncology, 99, 365-378.
https:/doi.org/10.1007/s11060-010-0349-8

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133